Other languages Cipla Limited

Equities

CIPLA

INE059A01026

Market Closed - NSE India S.E. Other stock markets 07:43:47 2024-04-26 am EDT			5-day change	1st Jan Change
1,409 ^INR	+0.21%		+4.71%	+13.07%

Apr. 24	Indian Equities End Higher Midweek as Iran-Israel Conflict Subsides	MT
Apr. 19	Cipla Limited Receives Order from the GST Authority	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Indian Equities End Higher Midweek as Iran-Israel Conflict Subsides	Apr. 24
India's Biocon developing its own version of Wegovy, clinical trial likely next year	Apr. 18
Indian Equities End Higher on Wednesday, Lifted Mainly by Metal Stocks	Apr. 10
Cipla Receives US FDA Observations Following Patalganga Facility Inspection	Apr. 05
Cipla Gets Regulatory Nod to Merge US-Based Subsidiaries	Mar. 26
Cipla to Distribute Sanofi's CNS Product Line in India	Mar. 26
Cipla Limited Appoints Rajeev Kumar Sinha as Senior Management Personnel and Global Chief Manufacturing Officer, Effective April 1, 2024	Mar. 26
Sanofi India Limited, Sanofi Healthcare India Private Limited and Cipla Limited Announce an Exclusive Partnership	Mar. 26
Losses Led by IT Drag Indian Equities on Tuesday	Mar. 19
Cipla Limited Appoints Venkata Sai Mungara as Senior Management Personnel and Global Head - Supply Chain, Effective from 1 April 2024	Mar. 15
Indian Equities Close with Marginal Gains on Tuesday as IT Stocks See Drop	Mar. 12
Cipla Arm Completes Sale of Entire Stake in Wellthy	Mar. 07
EXCLUSIVA-Eli Lilly podría lanzar un fármaco contra la obesidad en India el próximo año: presidente ejecutivo	Feb. 28
India pharma companies develop versions of Wegovy to get in on weight-loss windfall	Feb. 22
Indian Equities Close Higher Midweek, Led by Banking, IT Stocks	Feb. 14
Indian drugmaker Lupin beats quarterly profit estimates on strong demand	Feb. 07
Indian drugmaker J B Chemicals posts Q3 profit rise on strong demand	Feb. 06
India's Alembic Pharma beats Q3 profit view on strong domestic, US sales	Feb. 05
Cipla Eyes Acquisitions and Inorganic Partnerships in the US, European markets	Feb. 04
India's Jubilant Pharmova posts quarterly profit	Feb. 02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Cipla Limited

Equities

CIPLA

INE059A01026

Other languages

Filters